Antiretrovirals in Development

Overview

Results From Multi-Dose Vorinostat Trial (March 25, 2013)
Selected research highlight from CROI 2013.
In Michael Palm HIV Basic Science, Vaccines & Prevention Project Weblog, from Treatment Action Group
New Drugs for HIV Treatment and Other Random Thoughts (March 20, 2013)
From National AIDS Treatment Advocacy Project
Eradication/Cure, Prevention, Novel Strategies for Administration of PrEP (Delivery Alternatives), Antiretroviral Therapy/Drug Resistance/New Drugs/Comorbidities (March 17, 2013)
From National AIDS Treatment Advocacy Project
Challenges and Opportunities for the Development of Long-Acting Antiretrovirals (Video) (March 15, 2013)
From HIVandHepatitis.com
CROI 2013: The Latest on HIV Drugs in Development, Antiretroviral Strategy and Treatment as Prevention (Video) (March 14, 2013)
From International Foundation for Alternative Research in AIDS
CROI 2013: The Studies Most Likely to Make Waves (March 1, 2013)
What developments should a frontline care provider most look forward to at this year's CROI? Ben Young, M.D., Ph.D., shares his short list of to-watch studies and presentations.
In The 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013), from TheBodyPRO.com
The Hot List: Top 10 HIV Conference Articles of 2012 on TheBodyPRO.com (December 18, 2012)
From TheBodyPRO.com
Six Promising HIV Drugs in the Pipeline (December 5, 2012)
In IDWeek 2012, from TheBodyPRO.com
Drug News From ICAAC (November/December 2012)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
2012 Pipeline Report: HIV, Hepatitis C Virus (HCV) and Tuberculosis Drugs, Diagnostics, Vaccines and Preventive Technologies in Development (PDF) (July 2012)
From HIV i-Base and Treatment Action Group

VIEW ALL ARTICLES

MOST VIEWED ARTICLES

	HIV Management Today: Mental Health & HIV, the Uncharted Territory
	Danish Study Targets HIV Reservoir, in Latest Search for HIV Cure
	10 Top Studies Whose Impact Will Last Well Beyond CROI 2013
	CROI 2013: Women's Issues in HIV Research (Video)
	HIV Opportunistic Infection Guidelines Updated
	PrEP Failures and Successes: One Study Whose Impact Will Last Well Beyond CROI 2013

More Most Viewed Articles

TheBodyPRO.com is a service of Remedy Health Media, LLC, 500 5th Avenue, 19th Floor, New York, NY 10110. TheBodyPRO.com and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of TheBodyPRO.com's homepage, topic pages, page designs and HTML code. General Disclaimer: TheBodyPRO.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBodyPRO.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.